These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17493033)

  • 1. Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke.
    Mitsios N; Pennucci R; Krupinski J; Sanfeliu C; Gaffney J; Kumar P; Kumar S; Juan-Babot O; Slevin M
    Brain Pathol; 2007 Jan; 17(1):11-23. PubMed ID: 17493033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
    Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
    J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
    Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
    Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
    Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
    Zhang L; Liu W; Szumlinski KK; Lew J
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20041-6. PubMed ID: 23151508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.
    Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
    J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of Cdk5 activity after hypoxia/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats.
    Tan X; Chen Y; Li J; Li X; Miao Z; Xin N; Zhu J; Ge W; Feng Y; Xu X
    Neuroscience; 2015 Apr; 290():552-60. PubMed ID: 25665755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35.
    Amin ND; Zheng Y; Bk B; Shukla V; Skuntz S; Grant P; Steiner J; Bhaskar M; Pant HC
    Mol Biol Cell; 2016 Nov; 27(21):3221-3232. PubMed ID: 27630261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of cdk5 in Hippocampal sclerosis.
    Sen A; Thom M; Martinian L; Jacobs T; Nikolic M; Sisodiya SM
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):55-66. PubMed ID: 16410749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
    Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
    J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
    Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
    J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
    J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc induces CDK5 activation and neuronal death through CDK5-Tyr15 phosphorylation in ischemic stroke.
    Tuo QZ; Liuyang ZY; Lei P; Yan X; Shentu YP; Liang JW; Zhou H; Pei L; Xiong Y; Hou TY; Zhou XW; Wang Q; Wang JZ; Wang XC; Liu R
    Cell Death Dis; 2018 Aug; 9(9):870. PubMed ID: 30158515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
    Asada A; Saito T; Hisanaga S
    J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
    Zheng YL; Amin ND; Hu YF; Rudrabhatla P; Shukla V; Kanungo J; Kesavapany S; Grant P; Albers W; Pant HC
    J Biol Chem; 2010 Oct; 285(44):34202-12. PubMed ID: 20720012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic stroke injury is mediated by aberrant Cdk5.
    Meyer DA; Torres-Altoro MI; Tan Z; Tozzi A; Di Filippo M; DiNapoli V; Plattner F; Kansy JW; Benkovic SA; Huber JD; Miller DB; Greengard P; Calabresi P; Rosen CL; Bibb JA
    J Neurosci; 2014 Jun; 34(24):8259-67. PubMed ID: 24920629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
    Kesavapany S; Zheng YL; Amin N; Pant HC
    Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p25/cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons.
    Saito T; Konno T; Hosokawa T; Asada A; Ishiguro K; Hisanaga S
    J Neurochem; 2007 Jul; 102(1):133-40. PubMed ID: 17506859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.